Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

Fig. 3

MIR31HG expression in association with copy-number alterations. a MIR31HG showed 56.76% of shallow/deep deletion, 31.62% of diploid and 11.62% of gain/amplification. b Significantly higher expression of MIR31HG was observed in the subgroup with gain (median expression 7.46) and diploid (median expression 7.12) compared to deletion (median expression 4.77). c High expression of MIR31HG was observed in the subgroup with deletion and diploid than in gain (n = 47, 20.44% in gain; n = 99, 43.04% in diploid; n = 84, 36.52% in deletion), while low expression was observed in the subgroup with deletion compared to diploid and gain (n = 15, 8.67% in gain; n = 28, 16.18% in diploid; n = 130, 75.15% in deletion)

Back to article page